Lamotrigine-13C,D3 | CAS 2517756-06-6 - Request Quote
Lamotrigine-13C,D3
| SZ CAT No: | SZ-L014D03 |
| CAS No | 2517756-06-6 |
| Mol.F. | C813CH4D3Cl2N5 |
| Mol.Wt. | 260.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lamotrigine-13C,D3 is chemically 6-(2,3-Dichlorophenyl-4,5,6-d3)-1,2,4-triazine-3,5-diamine-5-13C. Lamotrigine-13C,D3 is supplied with detailed characterization data compliant with regulatory guideline. Lamotrigine-13C,D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lamotrigine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2517756-06-6
Purchase 2517756-06-6
Order 2517756-06-6
Enquire 2517756-06-6
price of 2517756-06-6
2517756-06-6 Supplier
2517756-06-6 Manufacturer
2517756-06-6 Exporter
buy high quality Lamotrigine-13C,D3
Purchase Lamotrigine-13C,D3
Lamotrigine-13C,D3 suppliers
Lamotrigine-13C,D3 manufacturers
Lamotrigine-13C,D3 price
Order Lamotrigine-13C,D3
Enquire Lamotrigine-13C,D3
Lamotrigine-13C,D3 cost
Lamotrigine-13C,D3 Supplier
Lamotrigine-13C,D3 Distributor
Lamotrigine-13C,D3 for Method Validation
Lamotrigine Reference Standard
Lamotrigine-13C,D3 for ANDA Filing
Lamotrigine-13C,D3 for Forced Degradation Studies
Lamotrigine-13C,D3 Identification Standards
Lamotrigine-13C,D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


